NGNENeurogene Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $20.69 (+0.00% today)

Market Cap: $322.23M

P/E (TTM): -3.50

Relative Strength (RS%): 1

-44.5% from 52-week high

Back to Scanner

NGNE

NASDAQRS 1Score 7

Neurogene Inc.

HealthcareBiotechnology$322.23M
$20.69
0.0% ($0.00)
-44.5% from 52W High
P/E (TTM)
-3.50
Fwd P/E
PEG
Analyst Upside
EPS Growth
Gross Margin
0.0%
ROE
-33.0%
D/E
0.04
Div Yield
0.0%
Avg Volume
182.6K

Price Chart

Key Levels

SMA 200
$21.27
SMA 50
$19.69
Price
$20.69
52W High
$37.28

Setup Radar

0/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst